John Temperato
Chief Commercial Officer, MELINTA THERAPEUTICS, INC. /NEW/.
Companies
- 9 METERS BIOPHARMA, INC.Board member May 4, 2020 to Mar 29, 20231
- 9 METERS BIOPHARMA, INC.Chief executive officer May 4, 2020 to Mar 29, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- 9 METERS BIOPHARMA, INC.140,192 shares2Mar 27, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 27, 2023Granted 68,815 shares of 9 METERS BIOPHARMA, INC.2
- Jul 6, 2022Bought 125,000 shares at $0.23 of 9 METERS BIOPHARMA, INC.3
- May 18, 2022Bought 50,000 shares at $0.45 of 9 METERS BIOPHARMA, INC.4
- Mar 3, 2022Bought 100,000 shares at $0.56 of 9 METERS BIOPHARMA, INC.5
- Nov 18, 2021Bought 50,000 shares at $1.05 of 9 METERS BIOPHARMA, INC.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jul 8, 2022
- 4SEC EDGARForm 4 filed May 19, 2022
- 5SEC EDGARForm 4 filed Mar 4, 2022
- 6SEC EDGARForm 4 filed Nov 19, 2021